The establishment of a cross-disciplinary epigenetics accelerator aims to expedite the translation of epigenetic research into clinical practice for cardiovascular diseases and beyond. This initiative promises to address patient anxieties about treatment options while fostering integration among researchers and regulators to streamline therapeutic approvals. With significant recognition of epigenetic modifications as vital in diagnostics and therapies, the initiative seeks to bridge existing gaps and enhance patient outcomes.
Title not available for this citation.
“Heart failure (HF) remains a major global health concern with high morbidity and mortality, particularly in cases with preserved ejection fraction, where treatment options are limited.”
Title not available for this citation.
“Epigenetic mechanisms, including DNA methylation, histone modification, and noncoding RNAs, are increasingly recognized for their role in HF development and progression.”
Title not available for this citation.
“Emerging pharmacologic agents, alongside repurposed drugs with epigenetic effects, show promising results.”
Title not available for this citation.
“Additionally, lifestyle factors such as diet and exercise influence the epigenome, opening new avenues for personalized, nonpharmacological interventions aimed at modifying disease trajectory and improving clinical outcomes.”
Title not available for this citation.
“Dilated cardiomyopathy (DCM) is a nonischemic heart muscle disease characterized by impaired contractility, cardiac dilation, and heart failure.”
Title not available for this citation.
“Emerging evidence highlights epigenetic mechanisms, including deoxyribonucleic acid methylation, histone modifications, chromatin remodeling, and noncoding RNAs, as critical regulators of gene expression in DCM pathogenesis.”
Title not available for this citation.
“This article explores familial DCM linked to pathogenic variants in genes like lamin A/C and titin.”
Title not available for this citation.
“It highlights the epigenetic factors in bridging genetic and environmental influences, offering potential biomarkers and therapeutic targets for improved DCM management.”
Title not available for this citation.
“Forensic DNA phenotyping applies genetic and epigenetic markers to infer biogeographical ancestry, physical appearance traits, and biological age, particularly when conventional methods fail to identify a suspect or victim.”
Title not available for this citation.
“Nanopore sequencing offers a promising alternative by enabling real-time, direct detection of methylation without DNA conversion.”
Title not available for this citation.
“Body fluid identification of blood and saliva was highly accurate in conditions with high and low read depth coverage, correctly identifying 4/4 sample in each experiment.”
Title not available for this citation.
“The mTOR/BTB mechanism is a novel pathway through which environmental and other stressors influence sperm epigenetic aging.”